Is Mould Exposure Making You Sick? Understanding the Spectrum of Mould-Related Illness
Living or working in a mould-affected or water-damaged building can contribute to a broad range of health problems. Symptoms may develop relatively quickly following a significant exposure, or emerge gradually over months or years, making the connection with the environment less obvious.
Importantly, mould-related illness is not one single condition. Some people predominantly develop allergic or respiratory symptoms, while others experience increased mast-cell activation or a much broader multisystem illness consistent with Chronic Inflammatory Response Syndrome (CIRS). Mould exposure can also aggravate health problems that were present before the exposure occurred.
The evidence is strongest for the relationship between damp and mould-affected buildings and respiratory and allergic disease. More recent research is examining the wider immunological and inflammatory effects of fungal exposure and the multisystem illness described in CIRS.
In practice, it is often the combination of symptoms, their timing and the history of exposure that raises suspicion. If multiple seemingly unrelated symptoms appeared after moving into a new home or workplace, following a significant water-damage event, or an existing health condition deteriorated substantially following exposure, it may be worth investigating whether mould is contributing.
Mould-Related Illness Exists on a Spectrum
A water-damaged building is a complex environment. Depending on the building and extent of moisture damage, occupants may be exposed to fungal spores and fragments, bacteria, β-glucans, endotoxins, mycotoxins and other microbial products.
This may partly explain why different people exposed to the same building can develop very different symptoms.
The relationship between damp buildings and respiratory health is well established. Reviews have found associations between indoor dampness and mould and asthma, wheezing, cough, shortness of breath, respiratory infections, bronchitis, allergic rhinitis and other upper respiratory symptoms (Mendell et al., 2011). More recent systematic review evidence has continued to support the relationship, with exposure to dampness and visible mould associated with an increased probability of developing asthma (Agache et al., 2024).
However, respiratory and allergic disease represents only part of the spectrum encountered clinically.
Allergic Mould Disease
Allergic illness is one of the best-established consequences of mould exposure.
People can become sensitised to fungal allergens including Alternaria, Aspergillus, Cladosporium and Penicillium. In someone who is sensitised, exposure may trigger an IgE-mediated allergic response.
A typical allergic symptom pattern may include:
sneezing and nasal congestion
runny or itchy nose
red, itchy or watery eyes
post-nasal drip and sinus congestion
skin irritation or eczema
coughing or wheezing
chest tightness or shortness of breath.
Mould exposure can also aggravate existing allergic rhinitis and asthma. Reviews of the research have found sufficient evidence of an association between indoor mould exposure and allergic rhinitis, while exposure to mould within workplaces has been associated with both the development and exacerbation of occupational asthma (Caillaud et al., 2018).
The relationship with a particular environment can sometimes be an important clue. Someone may develop persistent nasal congestion or wheezing at home, improve considerably when travelling and then deteriorate after returning. Alternatively, previously stable hay fever or asthma may become significantly more difficult to manage after moving into a damp or water-damaged building.
Respiratory Illness Beyond Mould Allergy
Not everyone experiencing respiratory symptoms following mould exposure has a conventional mould allergy.
This distinction is important because a person may undergo allergy testing, receive negative results and assume this means their symptoms cannot be related to the building.
Research suggests the relationship is more complex. Damp and mould exposure has been associated with cough, wheezing, breathlessness, bronchitis, respiratory infections and upper respiratory symptoms in both allergic and non-allergic populations (Mendell et al., 2011).
A respiratory presentation associated with a damp or mould-affected building may include:
chronic sinus congestion or post-nasal drip
recurrent sinusitis
chronic cough
wheezing
chest tightness
shortness of breath
recurrent respiratory infections.
There are also less common but important conditions associated with fungal exposure, including hypersensitivity pneumonitis and fungal infection in susceptible individuals. Persistent or significant respiratory symptoms therefore require appropriate medical assessment rather than automatically being attributed to mould.
Nevertheless, negative allergy testing by itself does not necessarily exclude the possibility that a water-damaged building is contributing to respiratory symptoms.
Mould Exposure and Mast-Cell Activation
Another presentation I frequently see in clinical practice is an increase in mast-cell and histamine-related symptoms following mould exposure.
Mast cells are immune cells located throughout the body, particularly in the respiratory and gastrointestinal tracts, skin and blood vessels. When activated they can release histamine, prostaglandins, leukotrienes and numerous other inflammatory mediators, producing symptoms across multiple systems.
A mast-cell pattern may include:
flushing, itching, hives or dermatographism
nasal congestion, coughing or wheezing
headaches, fatigue or brain fog
palpitations, dizziness or light-headedness
reflux, abdominal pain, nausea or diarrhoea
increased sensitivity to foods, alcohol, fragrances, heat, medications or supplements.
There is biological plausibility for a relationship between fungal exposure and mast-cell activation. Fungi can interact with mast cells and other components of innate immunity, and mast cells play an established role in fungal allergic responses (Saluja et al., 2012; Lopes et al., 2019).
However, the evidence that exposure to a water-damaged building directly causes Mast Cell Activation Syndrome (MCAS) is less established. Clinically, mould may therefore be better considered a potential trigger or amplifier of mast-cell activation in susceptible individuals.
There can also be considerable overlap between mast-cell symptoms and CIRS, particularly in people who become increasingly reactive to foods, fragrances, supplements and other environmental exposures as their illness progresses.
Chronic Inflammatory Response Syndrome (CIRS)
At the more complex end of the spectrum is Chronic Inflammatory Response Syndrome (CIRS).
CIRS describes a multisystem inflammatory illness that can develop in susceptible individuals following exposure to water-damaged buildings and the mixture of microbial fragments, biotoxins and other inflammatory substances present within these environments. Unlike mould allergy, CIRS is not primarily considered an IgE-mediated condition.
The clinical framework for CIRS was largely established by Dr Ritchie Shoemaker, who identified 37 recurring symptoms that differentiated affected patients from controls and organised these into 13 symptom clusters. More recent CIRS research continues to use this symptom-cluster approach alongside exposure history, clinical findings and biomarkers (Dooley, Vukelic & Jim, 2024; Dooley, 2025).
The CIRS symptom clusters encompass:
Fatigue and weakness
Headaches
Muscle aches and cramps
Unusual or sharp pains, including ‘ice-pick’ pains
Visual symptoms, including light sensitivity, red or watery eyes and blurred vision
Respiratory symptoms, including sinus congestion, cough and shortness of breath
Gastrointestinal symptoms, including abdominal pain and diarrhoea
Joint pain and morning stiffness
Cognitive symptoms, including poor memory, concentration difficulties, confusion, disorientation and difficulty finding words
Mood and temperature regulation changes, including mood changes and night sweats
Excessive thirst, frequent urination and increased static shocks
Neurological and sensory symptoms, including numbness, tingling and unusual taste sensations
Dizziness, vertigo and other neurological symptoms
The importance of these clusters is that CIRS is generally characterised by multiple symptoms across several body systems, rather than one or two isolated complaints.
This is also consistent with what I have observed managing patients with mould-related illness over many years. The combination of fatigue, cognitive changes, unusual pains, respiratory or sinus symptoms, gastrointestinal changes, night sweats, thirst and frequent urination can become a recognisable pattern when several occur together following a significant exposure. Static shocks are another less conventional symptom that I do see reported within this broader presentation.
The evidence base for CIRS is developing. Published research has described a consistent multisystem illness associated with water-damaged-building exposure alongside abnormalities in inflammatory markers, regulatory neuropeptides and neuroendocrine function. A recent review identified 13 published studies investigating CIRS treatment, including randomised controlled trials and observational research, although the evidence base remains relatively small and further independent research is required (Dooley, Vukelic & Jim, 2024).
CIRS provides a useful clinical framework when there is a characteristic multisystem symptom pattern, a credible history of exposure to a water-damaged building and supporting clinical findings, while other potential causes of the presentation are investigated in parallel.
Mould Can Aggravate Pre-existing Health Problems
Not everyone who develops problems following mould exposure was completely well beforehand.
In clinical practice, I commonly see people with pre-existing gastrointestinal, respiratory, allergic, immune or other chronic health problems that become substantially worse following exposure to a water-damaged environment.
Someone with previously manageable asthma may develop persistent respiratory symptoms. A person with mild food or histamine reactions may become increasingly reactive. Someone with an existing gastrointestinal disorder may notice a substantial deterioration in their digestive symptoms.
This is an important distinction because mould does not necessarily need to explain someone's entire medical history to be clinically relevant.
For some people, the exposure appears to be the event that initiates their illness. For others, it may act as an additional inflammatory or immune trigger that aggravates an existing vulnerability.
Understanding what changed around the time someone's health deteriorated can therefore be particularly important when assessing chronic illness.
The Pattern Is More Important Than Any Individual Symptom
Most symptoms associated with mould-related illness are not specific to mould.
Fatigue is common. So are headaches, brain fog, sinus congestion, gastrointestinal symptoms, dizziness and joint pain. Frequent urination and night sweats also have numerous possible causes.
Having one of these symptoms does not mean you have CIRS or another mould-related illness.
The situation becomes more significant when several symptoms affecting different physiological systems appear around the same time, particularly when there is also a plausible environmental exposure.
For example, someone may have previously been well but gradually develop sinus congestion, fatigue, poor concentration, headaches, gastrointestinal symptoms, unusual pains and night sweats after moving into a new home. They may later discover that the property has a significant history of water damage.
Another person may have pre-existing IBS, migraine, asthma or mast-cell symptoms that had previously been manageable but deteriorate substantially following a water leak or after moving into a damp building.
An additional clue can be a change in symptoms according to location. Some people notice that they feel considerably better when they spend several days or weeks away from their home or workplace, only for symptoms to return following re-exposure.
None of these observations proves that mould is responsible. However, collectively they provide a reasonable basis for investigating whether the environment is contributing.
When Should You Investigate Mould Further?
If you have one isolated symptom, mould is only one of many possible explanations.
However, if you are experiencing a number of symptoms from one or more of the patterns described above, particularly if they appeared or became substantially worse following a change in environment, it may be worth investigating further.
I become particularly interested in mould as a potential underlying trigger when:
several symptoms began after moving into a new home or workplace
symptoms followed a known leak, flooding or water-damage event
symptoms involve several different body systems
a pre-existing chronic condition deteriorated significantly after exposure
symptoms improve when away from the building and return following re-exposure
other people occupying the same environment have also developed symptoms.
The purpose of investigating further is not to assume that mould is responsible for every symptom. Many other conditions can produce similar presentations, and appropriate differential diagnosis remains important.
Rather, the aim is to rule mould-related illness in or out as a potential contributor.
The type of investigation will depend upon the presentation. Predominantly respiratory or allergic symptoms may require respiratory and allergy assessment. A mast-cell pattern may warrant further investigation of mast-cell activation and other potential causes. A broad multisystem presentation following exposure to a water-damaged building may warrant assessment for CIRS.
Environmental assessment is the other part of the picture. I discuss this separately in Assessing Your Home for Mould, including how to identify evidence of water damage, when professional building assessment may be appropriate and the role and limitations of environmental mould testing.
Putting the Pieces Together
Mould-related illness extends beyond a simple allergy to mould.
There is strong evidence linking damp and mould-affected buildings with respiratory and allergic disease. There is also increasing understanding of the interaction between fungi and the immune system, including mast cells, while a developing body of research supports the multisystem illness described as CIRS.
These presentations can also overlap. One person may predominantly have allergic respiratory symptoms, another may develop significant mast-cell reactivity, while another develops the broad symptom clusters characteristic of CIRS. Some people experience features of more than one pattern.
The most useful approach is therefore to consider the symptoms collectively, when they began, what happened to the person's health following exposure and whether there is credible evidence of a water-damaged environment.
If you have developed multiple unexplained symptoms after moving into a particular building, your health has deteriorated following water damage, or you consistently feel better when away from your home or workplace, investigating mould exposure may help determine whether an environmental trigger is contributing to your illness.
The objective is not to attribute every unexplained health problem to mould. It is to make sure that a potentially important underlying driver is not overlooked.
References
Agache, I. et al. (2024) ‘The impact of indoor pollution on asthma-related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma’, Allergy, 79(7), pp. 1761–1788. https://doi.org/10.1111/all.16051
Caillaud, D., Leynaert, B., Keirsbulck, M. & Nadif, R. (2018) ‘Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies’, European Respiratory Review, 27(148), 170137. https://doi.org/10.1183/16000617.0137-2017
Dooley, M., Vukelic, A. & Jim, L. (2024) ‘Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment’, Annals of Medicine & Surgery, 86(12), pp. 7248–7254. https://doi.org/10.1097/MS9.0000000000002718
Dooley, M. (2025) ‘Biomarkers over time: from visual contrast sensitivity to transcriptomics in differentiating Chronic Inflammatory Response Syndrome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome’, International Journal of Molecular Sciences, 26(15), 7284. https://doi.org/10.3390/ijms26157284
Lopes, J.P., Stylianou, M., Nilsson, G. & Urban, C.F. (2019) ‘Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells’, Scientific Reports, 9, 3325. https://doi.org/10.1038/s41598-019-39989-3
Mendell, M.J., Mirer, A.G., Cheung, K., Tong, M. & Douwes, J. (2011) ‘Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence’, Environmental Health Perspectives, 119(6), pp. 748–756. https://doi.org/10.1289/ehp.1002410
Saluja, R., Metz, M. & Maurer, M. (2012) ‘Role and relevance of mast cells in fungal infections’, Frontiers in Immunology, 3, 146. https://doi.org/10.3389/fimmu.2012.00146